MENLO PARK, Calif., May 16, 2025 /PRNewswire/ -- BillionToOne, Inc., a molecular diagnostics company with a mission to create the most powerful and accurate tests that are accessible to all, announced ...
The new offering provides precise fetal risk assessment for up to 14 prevalent and actionable recessive and X-linked conditions, in addition to aneuploidies, as early as nine weeks into pregnancy — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results